These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19164937)

  • 21. 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells.
    Steele AJ; Prentice AG; Hoffbrand AV; Yogashangary BC; Hart SM; Lowdell MW; Samuel ER; North JM; Nacheva EP; Chanalaris A; Kottaridis P; Cwynarski K; Wickremasinghe RG
    Blood; 2009 Aug; 114(6):1217-25. PubMed ID: 19515722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
    Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
    Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.
    Chen S; Dai Y; Harada H; Dent P; Grant S
    Cancer Res; 2007 Jan; 67(2):782-91. PubMed ID: 17234790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1.
    Larrayoz M; Blakemore SJ; Dobson RC; Blunt MD; Rose-Zerilli MJ; Walewska R; Duncombe A; Oscier D; Koide K; Forconi F; Packham G; Yoshida M; Cragg MS; Strefford JC; Steele AJ
    Leukemia; 2016 Feb; 30(2):351-60. PubMed ID: 26488112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced apoptosis in chronic lymphocytic leukemia.
    Stoetzer OJ; Pogrebniak A; Scholz M; Pelka-Fleischer R; Gullis E; Darsow M; Nüssler V; Wilmanns W
    Leukemia; 1999 Nov; 13(11):1873-80. PubMed ID: 10557065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plumbagin reduces chronic lymphocytic leukemia cell survival by downregulation of Bcl-2 but upregulation of the Bax protein level.
    Fu C; Gong Y; Shi X; Sun Z; Niu M; Sang W; Xu L; Zhu F; Wang Y; Xu K
    Oncol Rep; 2016 Sep; 36(3):1605-11. PubMed ID: 27461100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bcl-2 and Bax protein interaction in B-lymphocytes of peripheral blood in patients with chronic lymphocytic leukemia].
    Brajusković G; Orolicki SV; Cerović S; Usaj SK; Marjanović S; Romac S
    Vojnosanit Pregl; 2005 May; 62(5):357-63. PubMed ID: 15913039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
    Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
    Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
    Rosato RR; Almenara JA; Coe S; Grant S
    Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.
    Schwänen C; Hecker T; Hübinger G; Wölfle M; Rittgen W; Bergmann L; Karakas T
    Leukemia; 2002 Oct; 16(10):2096-105. PubMed ID: 12357363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells.
    Sanz L; Garcia-Marco JA; Casanova B; de La Fuente MT; García-Gila M; Garcia-Pardo A; Silva A
    Biochem Biophys Res Commun; 2004 Mar; 315(3):562-7. PubMed ID: 14975737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia.
    Goolsby C; Paniagua M; Tallman M; Gartenhaus RB
    Cytometry B Clin Cytom; 2005 Jan; 63(1):36-46. PubMed ID: 15624202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia.
    Jewell AP
    Leuk Lymphoma; 1996 Mar; 21(1-2):43-7. PubMed ID: 8907268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of the Bcl-2 family of proteins in peripheral blood B-lymphocytes in patients with chronic lymphocytic leukemia].
    Brajusković G; Vukosavić S; Dimitrijević J; Cerović S; Usaj SK; Marjanović S; Romac S; Milić AS
    Vojnosanit Pregl; 2004; 61(1):41-6. PubMed ID: 15022388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies.
    Kim H; Rafiuddin-Shah M; Tu HC; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH
    Nat Cell Biol; 2006 Dec; 8(12):1348-58. PubMed ID: 17115033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins.
    Bokelmann I; Mahlknecht U
    Mol Med; 2008; 14(1-2):20-7. PubMed ID: 17973028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches.
    Hallaert DY; Jaspers A; van Noesel CJ; van Oers MH; Kater AP; Eldering E
    Blood; 2008 Dec; 112(13):5141-9. PubMed ID: 18796631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific interactions of BCL-2 family proteins mediate sensitivity to BH3-mimetics in diffuse large B-cell lymphoma.
    Smith VM; Dietz A; Henz K; Bruecher D; Jackson R; Kowald L; van Wijk SJL; Jayne S; Macip S; Fulda S; Dyer MJS; Vogler M
    Haematologica; 2020 Aug; 105(8):2150-2163. PubMed ID: 31601689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.
    Merino D; Kelly GL; Lessene G; Wei AH; Roberts AW; Strasser A
    Cancer Cell; 2018 Dec; 34(6):879-891. PubMed ID: 30537511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
    Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
    Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.